{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:46:07Z","timestamp":1782881167832,"version":"3.54.5"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>HERC2<\/jats:italic>\n                    gene encodes an E3 ubiquitin ligase involved in several cellular processes by regulating the ubiquitylation of different protein substrates. Biallelic pathogenic sequence variants in the\n                    <jats:italic>HERC2<\/jats:italic>\n                    gene are associated with HERC2 Angelman-like syndrome. In pathogenic\n                    <jats:italic>HERC2<\/jats:italic>\n                    variants, complete absence or marked reduction in HERC2 protein levels are observed. The most common pathological variant, c.1781C\u2009&gt;\u2009T (p.Pro594Leu), encodes an unstable HERC2 protein. A better understanding of how pathologic\n                    <jats:italic>HERC2<\/jats:italic>\n                    variants affect intracellular signalling may aid definition of potential new therapies for these disorders. For this purpose, we studied patient-derived cells with the HERC2 Pro594Leu variant. We observed alteration of mitogen-activated protein kinase signalling pathways, reflected by increased levels of C-RAF protein and p38 phosphorylation. HERC2 knockdown experiments reproduced the same effects in other human and mouse cells. Moreover, we demonstrated that HERC2 and RAF proteins form molecular complexes, pull-down and proteomic experiments showed that HERC2 regulates C-RAF ubiquitylation and we found out that the p38 activation due to HERC2 depletion occurs in a RAF\/MKK3-dependent manner. The displayed cellular response was that patient-derived and other human cells with HERC2 deficiency showed higher resistance to oxidative stress with an increase in the master regulator of the antioxidant response NRF2 and its target genes. This resistance was independent of p53 and abolished by RAF or p38 inhibitors. Altogether, these findings identify the activation of C-RAF\/MKK3\/p38 signalling pathway in HERC2 Angelman-like syndrome and highlight the inhibition of RAF activity as a potential therapeutic option for individuals affected with these rare diseases.\n                  <\/jats:p>","DOI":"10.1007\/s00018-022-04586-7","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T16:10:55Z","timestamp":1665763855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["HERC2 deficiency activates C-RAF\/MKK3\/p38 signalling pathway altering the cellular response to oxidative stress"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1947-7944","authenticated-orcid":false,"given":"Joan","family":"Sala-Gaston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Pedrazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanma","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lettie E.","family":"Rawlins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma L.","family":"Baple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew H.","family":"Crosby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Mayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-5688","authenticated-orcid":false,"given":"Jose Luis","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"4586_CR1","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","volume":"43","author":"I Parenti","year":"2020","unstructured":"Parenti I, Rabaneda LG, Schoen H, Novarino G (2020) Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci 43:608\u2013621. https:\/\/doi.org\/10.1016\/j.tins.2020.05.004","journal-title":"Trends Neurosci"},{"key":"4586_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01014","author":"J Garc\u00eda-Cano","year":"2019","unstructured":"Garc\u00eda-Cano J, Martinez-Martinez A, Sala-Gaston J et al (2019) HERCing: structural and functional relevance of the large HERC ubiquitin ligases. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2019.01014","journal-title":"Front Physiol"},{"key":"4586_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-biochem-051810-094654","volume":"81","author":"K Husnjak","year":"2012","unstructured":"Husnjak K, Dikic I (2012) Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81:291\u2013322. https:\/\/doi.org\/10.1146\/annurev-biochem-051810-094654","journal-title":"Annu Rev Biochem"},{"key":"4586_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12061653","volume":"12","author":"J Sala-Gaston","year":"2020","unstructured":"Sala-Gaston J, Martinez-Martinez A, Pedrazza L et al (2020) Herc ubiquitin ligases in cancer. Cancers (Basel) 12:1\u201313. https:\/\/doi.org\/10.3390\/cancers12061653","journal-title":"Cancers (Basel)"},{"key":"4586_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/onc.2012.539","volume":"33","author":"TH Lee","year":"2014","unstructured":"Lee TH, Park JM, Leem SH, Kang TH (2014) Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair. Oncogene 33:19\u201325. https:\/\/doi.org\/10.1038\/onc.2012.539","journal-title":"Oncogene"},{"key":"4586_CR6","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1158\/0008-5472.CAN-14-2315","volume":"75","author":"Y Peng","year":"2015","unstructured":"Peng Y, Dai H, Wang E et al (2015) TUSC4 functions as a tumor suppressor by regulating BRCA1 stability. Cancer Res 75:378\u2013386. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-2315","journal-title":"Cancer Res"},{"key":"4586_CR7","doi-asserted-by":"publisher","first-page":"13110","DOI":"10.1093\/nar\/gku1034","volume":"42","author":"J Yuan","year":"2014","unstructured":"Yuan J, Luo K, Deng M et al (2014) HERC2-USP20 axis regulates DNA damage checkpoint through Claspin. Nucleic Acids Res 42:13110\u201313121. https:\/\/doi.org\/10.1093\/nar\/gku1034","journal-title":"Nucleic Acids Res"},{"key":"4586_CR8","doi-asserted-by":"publisher","first-page":"13074","DOI":"10.1093\/nar\/gku978","volume":"42","author":"M Zhu","year":"2014","unstructured":"Zhu M, Zhao H, Liao J, Xu X (2014) HERC2\/USP20 coordinates CHK1 activation by modulating CLASPIN stability. Nucleic Acids Res 42:13074\u201313081. https:\/\/doi.org\/10.1093\/nar\/gku978","journal-title":"Nucleic Acids Res"},{"key":"4586_CR9","doi-asserted-by":"publisher","first-page":"6371","DOI":"10.1158\/0008-5472.CAN-18-1877","volume":"78","author":"W Wu","year":"2018","unstructured":"Wu W, Rokutanda N, Takeuchi J et al (2018) HERC2 facilitates BLM and WRN helicase complex interaction with RPA to suppress G-quadruplex DNA. Cancer Res 78:6371\u20136385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1877","journal-title":"Cancer Res"},{"key":"4586_CR10","doi-asserted-by":"publisher","first-page":"14782","DOI":"10.1074\/jbc.M113.527978","volume":"289","author":"M Cubillos-Rojas","year":"2014","unstructured":"Cubillos-Rojas M, Amair-Pinedo F, Peir\u00f3-Jord\u00e1n R et al (2014) The E3 ubiquitin protein ligase HERC2 modulates the activity of tumor protein p53 by regulating its oligomerization. J Biol Chem 289:14782\u201314795. https:\/\/doi.org\/10.1074\/jbc.M113.527978","journal-title":"J Biol Chem"},{"key":"4586_CR11","doi-asserted-by":"publisher","first-page":"61824","DOI":"10.18632\/oncotarget.18699","volume":"8","author":"M Cubillos-Rojas","year":"2017","unstructured":"Cubillos-Rojas M, Schneider T, Bartrons R et al (2017) NEURL4 regulates the transcriptional activity of tumor suppressor protein p53 by modulating its oligomerization. Oncotarget 8:61824\u201361836. https:\/\/doi.org\/10.18632\/oncotarget.18699","journal-title":"Oncotarget"},{"key":"4586_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/1878-0261.12592","volume":"14","author":"J Garc\u00eda-Cano","year":"2020","unstructured":"Garc\u00eda-Cano J, S\u00e1nchez-Tena S, Sala-Gaston J et al (2020) Regulation of the MDM2-p53 pathway by the ubiquitin ligase HERC2. Mol Oncol 14:69\u201386. https:\/\/doi.org\/10.1002\/1878-0261.12592","journal-title":"Mol Oncol"},{"key":"4586_CR13","doi-asserted-by":"publisher","first-page":"56083","DOI":"10.18632\/oncotarget.11270","volume":"7","author":"M Cubillos-Rojas","year":"2016","unstructured":"Cubillos-Rojas M, Schneider T, Hadjebi O et al (2016) The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination. Oncotarget 7:56083\u201356106. https:\/\/doi.org\/10.18632\/oncotarget.11270","journal-title":"Oncotarget"},{"key":"4586_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2021.11.017","author":"EM P\u00e9rez-Villegas","year":"2021","unstructured":"P\u00e9rez-Villegas EM, Ruiz R, Bachiller S et al (2021) The HERC proteins and the nervous system. Semin Cell Dev Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2021.11.017","journal-title":"Semin Cell Dev Biol"},{"key":"4586_CR15","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/humu.22237","volume":"33","author":"EG Puffenberger","year":"2012","unstructured":"Puffenberger EG, Jinks RN, Wang H et al (2012) A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder. Hum Mutat 33:1639\u20131646. https:\/\/doi.org\/10.1002\/humu.22237","journal-title":"Hum Mutat"},{"key":"4586_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/jmedgenet-2012-101367","volume":"50","author":"GV Harlalka","year":"2013","unstructured":"Harlalka GV, Baple EL, Cross H et al (2013) Mutation of HERC2 causes developmental delay with angelman-like features. J Med Genet 50:65\u201373. https:\/\/doi.org\/10.1136\/jmedgenet-2012-101367","journal-title":"J Med Genet"},{"key":"4586_CR17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/ejhg.2016.139","volume":"25","author":"F Morice-Picard","year":"2016","unstructured":"Morice-Picard F, Benard G, Rezvani HR et al (2016) Complete loss of function of the ubiquitin ligase HERC2 causes a severe neurodevelopmental phenotype. Eur J Hum Genet 25:52\u201358. https:\/\/doi.org\/10.1038\/ejhg.2016.139","journal-title":"Eur J Hum Genet"},{"key":"4586_CR18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1136\/jmedgenet-2020-106873","volume":"58","author":"M Elpidorou","year":"2021","unstructured":"Elpidorou M, Best S, Poulter JA et al (2021) Novel loss-of-function mutation in HERC2 is associated with severe developmental delay and paediatric lethality. J Med Genet 58:334\u2013341. https:\/\/doi.org\/10.1136\/jmedgenet-2020-106873","journal-title":"J Med Genet"},{"key":"4586_CR19","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/cge.14039","volume":"100","author":"KM Vincent","year":"2021","unstructured":"Vincent KM, Eaton A, Yassaee VR et al (2021) Delineating the expanding phenotype of HERC2-related disorders: the impact of biallelic loss of function versus missense variation. Clin Genet 100:637\u2013640. https:\/\/doi.org\/10.1111\/cge.14039","journal-title":"Clin Genet"},{"key":"4586_CR20","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.bbrc.2019.02.149","volume":"512","author":"JR Abraham","year":"2019","unstructured":"Abraham JR, Barnard J, Wang H et al (2019) Proteomic investigations of human HERC2 mutants: Insights into the pathobiology of a neurodevelopmental disorder. Biochem Biophys Res Commun 512:421\u2013427. https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.149","journal-title":"Biochem Biophys Res Commun"},{"key":"4586_CR21","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1158\/0008-5472.CAN-10-1304","volume":"70","author":"W Wu","year":"2010","unstructured":"Wu W, Sato K, Koike A et al (2010) HERC2 is an E3 ligase that targets BRCA1 for degradation. Cancer Res 70:6384\u20136392. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1304","journal-title":"Cancer Res"},{"key":"4586_CR22","doi-asserted-by":"publisher","first-page":"31531","DOI":"10.18632\/oncotarget.25847","volume":"9","author":"T Schneider","year":"2018","unstructured":"Schneider T, Martinez-Martinez A, Cubillos-Rojas M et al (2018) The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation. Oncotarget 9:31531\u201331548. https:\/\/doi.org\/10.18632\/oncotarget.25847","journal-title":"Oncotarget"},{"key":"4586_CR23","doi-asserted-by":"publisher","first-page":"19789","DOI":"10.1074\/jbc.M114.569392","volume":"289","author":"NC Chan","year":"2014","unstructured":"Chan NC, Den Besten W, Sweredoski MJ et al (2014) Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2. J Biol Chem 289:19789\u201319798. https:\/\/doi.org\/10.1074\/jbc.M114.569392","journal-title":"J Biol Chem"},{"key":"4586_CR24","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1128\/mcb.01246-12","volume":"33","author":"T Erazo","year":"2013","unstructured":"Erazo T, Moreno A, Ruiz-Babot G et al (2013) Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex. Mol Cell Biol 33:1671\u20131686. https:\/\/doi.org\/10.1128\/mcb.01246-12","journal-title":"Mol Cell Biol"},{"key":"4586_CR25","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.3390\/ijms22094851","volume":"22","author":"J Ramirez","year":"2021","unstructured":"Ramirez J, Prieto G, Olazabal-Herrero A et al (2021) A proteomic approach for systematic mapping of substrates of human deubiquitinating enzymes. Int J Mol Sci 22:4851. https:\/\/doi.org\/10.3390\/ijms22094851","journal-title":"Int J Mol Sci"},{"key":"4586_CR26","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.cell.2006.01.040","volume":"124","author":"J Moffat","year":"2006","unstructured":"Moffat J, Grueneberg DA, Yang X et al (2006) A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124:1283\u20131298. https:\/\/doi.org\/10.1016\/j.cell.2006.01.040","journal-title":"Cell"},{"key":"4586_CR27","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.bbamcr.2008.08.011","volume":"1783","author":"E Casas-Terradellas","year":"2008","unstructured":"Casas-Terradellas E, Tato I, Bartrons R et al (2008) ERK and p38 pathways regulate amino acid signalling. Biochim Biophys Acta Mol Cell Res 1783:2241\u20132254. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.08.011","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"4586_CR28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/elps.200900657","volume":"31","author":"M Cubillos-Rojas","year":"2010","unstructured":"Cubillos-Rojas M, Amair-Pinedo F, Tato I et al (2010) Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris-acetate polyacrylamide gels. Electrophoresis 31:1318\u20131321. https:\/\/doi.org\/10.1002\/elps.200900657","journal-title":"Electrophoresis"},{"key":"4586_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41598-020-57756-7","volume":"10","author":"L Pedrazza","year":"2020","unstructured":"Pedrazza L, Schneider T, Bartrons R et al (2020) The ubiquitin ligase HERC1 regulates cell migration via RAF-dependent regulation of MKK3\/p38 signaling. Sci Rep 10:824. https:\/\/doi.org\/10.1038\/s41598-020-57756-7","journal-title":"Sci Rep"},{"key":"4586_CR30","doi-asserted-by":"publisher","first-page":"7420","DOI":"10.1074\/jbc.270.13.7420","volume":"270","author":"J Raingeaud","year":"1995","unstructured":"Raingeaud J, Gupta S, Rogers JS et al (1995) Pro-inflammatory cytokines and environmental stress cause p38 mitogen- activated protein kinase activation by dual phosphorylation on tyrosine and threonine. J Biol Chem 270:7420\u20137426. https:\/\/doi.org\/10.1074\/jbc.270.13.7420","journal-title":"J Biol Chem"},{"key":"4586_CR31","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.1038\/s41388-020-1263-y","volume":"39","author":"T Brummer","year":"2020","unstructured":"Brummer T, McInnes C (2020) RAF kinase dimerization: implications for drug discovery and clinical outcomes. Oncogene 39:4155\u20134169. https:\/\/doi.org\/10.1038\/s41388-020-1263-y","journal-title":"Oncogene"},{"key":"4586_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","volume":"1865","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Giambanco I, Minelli A, Donato R (2018) Nrf2-Keap1 signaling in oxidative and reductive stress. BBA Mol Cell Res 1865:721\u2013733. https:\/\/doi.org\/10.1016\/j.bbamcr.2018.02.010","journal-title":"BBA Mol Cell Res"},{"key":"4586_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.08.034","volume":"183","author":"AG Manford","year":"2020","unstructured":"Manford AG, Rodr\u00edguez-P\u00e9rez F, Shih KY et al (2020) A cellular mechanism to detect and alleviate reductive stress. Cell 183:46-61.e21. https:\/\/doi.org\/10.1016\/j.cell.2020.08.034","journal-title":"Cell"},{"key":"4586_CR34","doi-asserted-by":"publisher","first-page":"5375","DOI":"10.1016\/j.cell.2021.09.002","volume":"184","author":"AG Manford","year":"2021","unstructured":"Manford AG, Mena EL, Shih KY et al (2021) Structural basis and regulation of the reductive stress response. Cell 184:5375-5390.e16. https:\/\/doi.org\/10.1016\/j.cell.2021.09.002","journal-title":"Cell"},{"key":"4586_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1021\/pr501005v","volume":"14","author":"T Galligan","year":"2015","unstructured":"Galligan T, Martinez-noe G, Arndt V et al (2015) Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. J Proteome Res 14:953\u2013966. https:\/\/doi.org\/10.1021\/pr501005v","journal-title":"J Proteome Res"},{"key":"4586_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41580-020-00322-w","volume":"22","author":"B Canovas","year":"2021","unstructured":"Canovas B, Nebreda AR (2021) Diversity and versatility of p38 kinase signalling in health and disease. Nat Rev Mol Cell Biol 22:346\u2013366. https:\/\/doi.org\/10.1038\/s41580-020-00322-w","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4586_CR37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","volume":"34","author":"M Rojo de la Vega","year":"2018","unstructured":"Rojo de la Vega M, Chapman E, Zhang DD (2018) NRF2 and the Hallmarks of cancer. Cancer Cell 34:21\u201343. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.022","journal-title":"Cancer Cell"},{"key":"4586_CR38","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","volume":"88","author":"T Suzuki","year":"2015","unstructured":"Suzuki T, Yamamoto M (2015) Molecular basis of the Keap1-Nrf2 system. Free Radic Biol Med 88:93\u2013100. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.06.006","journal-title":"Free Radic Biol Med"},{"key":"4586_CR39","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1124\/mol.58.5.1017","volume":"58","author":"KW Kang","year":"2000","unstructured":"Kang KW, Ryu JIH, Kim SG (2000) The essential role of phosphatidylinositol 3-kinase and of p38 mitogen-activated protein kinase activation in the antioxidant response element-mediated rGSTA2 induction by decreased glutathione in H4IIE hepatoma cells. Mol Pharmacol 58:1017\u20131025. https:\/\/doi.org\/10.1124\/mol.58.5.1017","journal-title":"Mol Pharmacol"},{"key":"4586_CR40","doi-asserted-by":"publisher","first-page":"27694","DOI":"10.1074\/jbc.M004729200","volume":"275","author":"J Alam","year":"2000","unstructured":"Alam J, Wicks C, Stewart D et al (2000) Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells: role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275:27694\u201327702. https:\/\/doi.org\/10.1074\/jbc.M004729200","journal-title":"J Biol Chem"},{"key":"4586_CR41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1006\/bbrc.2000.3830","volume":"278","author":"LM Zipper","year":"2000","unstructured":"Zipper LM, Mulcahy RT (2000) Inhibition of ERK and p38 MAP kinases inhibits binding of Nrf2 and induction of GCS genes. Biochem Biophys Res Commun 278:484\u2013492. https:\/\/doi.org\/10.1006\/bbrc.2000.3830","journal-title":"Biochem Biophys Res Commun"},{"key":"4586_CR42","doi-asserted-by":"publisher","first-page":"39907","DOI":"10.1074\/jbc.M004037200","volume":"275","author":"R Yu","year":"2000","unstructured":"Yu R, Chen C, Mo YY et al (2000) Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J Biol Chem 275:39907\u201339913. https:\/\/doi.org\/10.1074\/jbc.M004037200","journal-title":"J Biol Chem"},{"key":"4586_CR43","doi-asserted-by":"publisher","first-page":"42769","DOI":"10.1074\/jbc.M206911200","volume":"277","author":"HC Huang","year":"2002","unstructured":"Huang HC, Nguyen T, Pickett CB (2002) Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J Biol Chem 277:42769\u201342774. https:\/\/doi.org\/10.1074\/jbc.M206911200","journal-title":"J Biol Chem"},{"key":"4586_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21:1\u201323. https:\/\/doi.org\/10.3390\/ijms21134777","journal-title":"Int J Mol Sci"},{"key":"4586_CR45","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1074\/jbc.M111.323709","volume":"287","author":"\u00c1 Guti\u00e9rrez-Uzquiza","year":"2012","unstructured":"Guti\u00e9rrez-Uzquiza \u00c1, Arechederra M, Bragado P et al (2012) p38\u03b1 mediates cell survival in response to oxidative stress via induction of antioxidant genes: effect on the p70S6K pathway. J Biol Chem 287:2632\u20132642. https:\/\/doi.org\/10.1074\/jbc.M111.323709","journal-title":"J Biol Chem"},{"key":"4586_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3389\/fonc.2019.00524","volume":"9","author":"T Schneider","year":"2019","unstructured":"Schneider T, Martinez-Martinez A, Cubillos-Rojas M et al (2019) Large HERCS function as tumor suppressors. Front Oncol 9:524. https:\/\/doi.org\/10.3389\/fonc.2019.00524","journal-title":"Front Oncol"},{"key":"4586_CR47","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"B Perillo","year":"2020","unstructured":"Perillo B, Di DM, Pezone A et al (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52:192\u2013203. https:\/\/doi.org\/10.1038\/s12276-020-0384-2","journal-title":"Exp Mol Med"},{"key":"4586_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nature10189","volume":"475","author":"GM Denicola","year":"2011","unstructured":"Denicola GM, Karreth FA, Humpton TJ et al (2011) Oncogene-induced Nrf2 transcriptionpromotes ROS detoxification and tumorigenesis. Nature 475:106\u2013109. https:\/\/doi.org\/10.1038\/nature10189","journal-title":"Nature"},{"key":"4586_CR49","doi-asserted-by":"publisher","first-page":"20508","DOI":"10.18632\/oncotarget.24974","volume":"9","author":"K Lisek","year":"2018","unstructured":"Lisek K, Campaner E, Ciani Y et al (2018) Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells. Oncotraget 9:20508\u201320523. https:\/\/doi.org\/10.18632\/oncotarget.24974","journal-title":"Oncotraget"},{"key":"4586_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/649079","volume":"2012","author":"SAL Correa","year":"2012","unstructured":"Correa SAL, Eales KL (2012) The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease. J Signal Transduct 2012:649079. https:\/\/doi.org\/10.1155\/2012\/649079","journal-title":"J Signal Transduct"},{"key":"4586_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1006\/nbdi.2000.0299","volume":"7","author":"D Jaarsma","year":"2000","unstructured":"Jaarsma D, Haasdijk ED, Grashorn JAC et al (2000) Human Cu\/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mut. Neurobiol Dis 7:623\u2013643. https:\/\/doi.org\/10.1006\/nbdi.2000.0299","journal-title":"Neurobiol Dis"},{"key":"4586_CR52","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3389\/fnana.2017.00022","volume":"11","author":"P Afshar","year":"2017","unstructured":"Afshar P, Ashtari N, Jiao X et al (2017) Overexpression of human SOD1 leads to discrete defects in the cerebellar architecture in the mouse. Front Neuroanat 11:22. https:\/\/doi.org\/10.3389\/fnana.2017.00022","journal-title":"Front Neuroanat"},{"key":"4586_CR53","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2010.3587","volume":"14","author":"NS Rajasekaran","year":"2011","unstructured":"Rajasekaran NS, Varadharaj S, Khanderao GD et al (2011) Sustained activation of nuclear erythroid 2-related factor 2\/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice. Antioxidants Redox Signal 14:957\u2013971. https:\/\/doi.org\/10.1089\/ars.2010.3587","journal-title":"Antioxidants Redox Signal"},{"key":"4586_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5136957","author":"WX Ma","year":"2020","unstructured":"Ma WX, Li CY, Tao R et al (2020) Reductive stress-induced mitochondrial dysfunction and cardiomyopathy. Oxid Med Cell Longev. https:\/\/doi.org\/10.1155\/2020\/5136957","journal-title":"Oxid Med Cell Longev"},{"key":"4586_CR55","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1089\/ars.2019.7803","volume":"32","author":"W Xiao","year":"2020","unstructured":"Xiao W, Loscalzo J (2020) Metabolic responses to reductive stress. Antioxidants Redox Signal 32:1330\u20131347. https:\/\/doi.org\/10.1089\/ars.2019.7803","journal-title":"Antioxidants Redox Signal"},{"key":"4586_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505\u2013518. https:\/\/doi.org\/10.1038\/nrn2417","journal-title":"Nat Rev Neurosci"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04586-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04586-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04586-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T06:12:24Z","timestamp":1669702344000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04586-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4586"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04586-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1600424\/v1","asserted-by":"object"}]},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"548"}}